Godrej Agrovet Ltd

Godrej Agrovet Limited announced the allotment of 51,423 equity shares to eligible employees under its Employees Stock Grant Scheme 2018 (ESGS 2018). This allotment, valued at ₹5,14,230, increased the company's paid-up equity share capital to ₹192,41,13,900. Concurrently, the Nomination and Remuneration Committee noted the lapse of 10,329 stock options previously granted under the same scheme, primarily due to cessation of employment. The newly allotted shares will rank pari passu with existing equity shares.

Godrej Agrovet Limited (GAVL) announced its financial results for the first quarter ended June 30, 2026. Consolidated sales reached ₹2,852 crore, a growth from ₹2,603 crore in Q1 FY26. Profit before tax (excluding non-recurring items) stood at ₹172 crore, down from ₹188 crore in the prior year's quarter. The company cited delayed monsoons and geopolitical tensions leading to inflationary pressures as key challenges impacting profitability, particularly in the Crop Care business. However, Animal Nutrition and Oil Palm businesses showed strong performance, with double-digit volume growth in cattle feed and improved realizations in oil palm. Astec LifeSciences is progressing on its turnaround, achieving EBITDA break-even. The Dairy business saw increased value-added product share, and Godrej Foods maintained stable revenues despite input cost pressures.

Godrej Agrovet Limited announced the appointment of Mr. Ravishankar A. as Chief Financial Officer (CFO) Designate, effective September 21, 2026, and as the CFO from October 1, 2026. This follows the early superannuation of the current CFO, Mr. S. Varadaraj, effective September 30, 2026. The board also approved the unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at ₹2,203.47 crore (standalone) and ₹2,852.20 crore (consolidated). Limited review reports with unmodified opinions were noted.

Godrej Agrovet Limited announced the outcome of its Board Meeting held on August 5, 2026. The Board approved the unaudited financial results for the quarter ended June 30, 2026, both standalone and consolidated. They also noted the unmodified limited review reports on these results. A significant management change was approved with the early superannuation of Mr. S. Varadaraj as CFO & Head – Finance & Legal, effective September 30, 2026. Concurrently, Mr. Ravishankar A. has been appointed as CFO-Designate from September 21, 2026, and will assume the role of Chief Financial Officer from October 1, 2026. The company reported consolidated revenue from operations of ₹2,855.22 crore for the quarter.

Godrej Agrovet Limited announced its unaudited financial results for the quarter ended June 30, 2026. The Board of Directors approved the standalone and consolidated results, which were also noted along with their respective limited review reports. The company also noted the early superannuation of Mr. S. Varadaraj as CFO & Head – Finance & Legal, effective September 30, 2026. Mr. Ravishankar A. has been appointed as CFO-Designate from September 21, 2026, and will assume the role of CFO from October 1, 2026.

Godrej Agrovet's consolidated Q1 FY27 (quarter ended June 30, 2026) revenue rose 9.2% YoY to ₹2,855.22 Cr, but consolidated PAT ("profit for the period") fell 13.8% YoY to ₹128.31 Cr (EPS ₹6.99 vs ₹8.35 a year ago), even as it rebounded 25.4% QoQ from a seasonally soft Q4 FY26 base of ₹102.28 Cr — that sequential jump reflects the return of the Q1 kharif-season pickup in an agri-linked business rather than a structural improvement, and should not be read as trend confirmation. Consolidated PBT (before exceptional items, including share of JV profit) fell 9.7% YoY to ₹181.13 Cr. Neither this quarter nor the year-ago quarter carried any exceptional items at the consolidated level, so the decline is entirely operating in nature. The compression sits on operating margin: OPM eased to 8.41% from 10.32% a year ago (though up sequentially from Q4's seasonal low of 5.96%), while NPM fell to 4.49% from 5.69%. By segment, Crop Care Business (which houses Astec Lifesciences' agrochemical/CDMO operations) was the primary drag — revenue fell 13.3% YoY to ₹349.02 Cr and segment PBIT dropped 35.1% YoY to ₹75.55 Cr. Poultry & processed food PBIT collapsed 80.5% YoY to ₹0.87 Cr, and Dairy swung to a small segment loss of ₹(1.90) Cr from a ₹4.31 Cr profit despite 11.5% revenue growth. Offsetting this, Animal Nutrition (+12.6% revenue, +29.7% PBIT YoY) and the Vegetable Oil/Oil Palm business (+24.1% revenue, +14.7% PBIT YoY) delivered the momentum management had flagged — the latter coinciding with the inauguration of India's first integrated Oil Palm complex on July 20, 2026. Against management's own guidance from the Q4 FY26 call — early double-digit consolidated revenue growth and mid-teens PBT growth for FY27, with Crop Care recovery expected only from Q2 and a continued Astec CDMO-led turnaround — Q1's 9.2% revenue growth trails the "early double-digit" mark, and PBT declined rather than growing mid-teens, a clear miss on pace even though management had itself signalled that Crop Care weakness would persist through Q1. No management press release accompanied this filing, so there is no company framing to cross-check against the numbers, and no reliable Street consensus estimates for this specific quarter turned up in public previews, so the print cannot be benchmarked against consensus. Standalone PAT, by contrast, rose 8.7% YoY to ₹183.60 Cr — the divergence from consolidated (>3%) owes mainly to a ₹49.7 Cr JV dividend booked at the standalone level (eliminated on consolidation) and to weaker subsidiary-level performance (Astec, Crop Care, Poultry) that only shows up post-consolidation. Separately, the company disclosed a CFO transition alongside results: S. Varadaraj will take early superannuation effective September 30, 2026, with Ravishankar A. (previously VP-Finance at HUL's Beauty & Wellbeing business) named incoming CFO from October 1, 2026, with no stated link to the quarter's performance. This sets up Q2 FY27 as the checkpoint for the guided Crop Care recovery and for whether full-year PBT growth can still close the gap to the guided mid-teens pace after a Q1 shortfall.

Godrej Agrovet Limited has informed shareholders about the deduction of Tax at Source (TDS) on the Final Dividend for the Financial Year 2025-26. The Board had recommended a dividend of 110% (₹11 per equity share) on April 30, 2026, subject to shareholder approval at the 35th AGM on August 5, 2026. The record date for dividend entitlement is July 29, 2026. TDS will be deducted as per the new Income Tax Act, 2025, based on shareholder residency and PAN status. Resident individuals receiving less than ₹10,000 in total dividends in FY26 will be exempt from TDS. Shareholders can submit Form 121 for potential TDS exemption under specific conditions.

Godrej Agrovet Limited (GAVL) has inaugurated India's first Integrated Oil Palm Complex in Khammam, Telangana. This facility integrates the entire oil palm value chain, from seed and genetics to a nursery, R&D center, mill, and an upcoming refinery. The cumulative investment in the complex will reach INR 300 Crore once fully operational. The inauguration was attended by several dignitaries from the Government of Telangana and key GAVL management. The complex aims to support the company's expansion plans and contribute to India's edible oil security.

Godrej Agrovet Ltd has announced that its Board of Directors will convene on August 5, 2026. The primary agenda item for this meeting is to consider and approve the standalone and consolidated unaudited financial results for the quarter ended June 30, 2026. These results will be reviewed by the Audit Committee prior to the board's consideration. The company has also made this information available on its official website.

Godrej Agrovet Limited has announced the record date for the payment of a potential final dividend, to be declared at its 35th Annual General Meeting (AGM). The AGM is scheduled for August 5, 2026, and will be conducted via Video Conferencing. The company has also released its Annual Report for FY 2025-26, which includes the AGM notice. The Register of Members and Share Transfer Books will be closed from July 30, 2026, to August 4, 2026, for the AGM and dividend payment. The record date for determining eligibility for the dividend is July 29, 2026. Remote e-voting will be open from August 1 to August 4, 2026.